Speaking from the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland, Keith Kerr, MB, ChB, FRCPath, FRCPE, from the University of Aberdeen, Aberdeen, UK, describes the increasing complexity of the role of pathologists in the field of lung cancer, with an increasing number of assays required for appropriate treatment selection.
The role of the pathologist in the field of lung cancer
